Sanofi-Aventis S.A. ADR (SNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
Sales | 9,903,766 | 10,373,220 | 9,384,717 | 8,746,170 | 0 |
Cost of Goods | 3,195,305 | 3,098,016 | 2,849,981 | 2,699,531 | 0 |
Gross Profit | 6,708,460 | 7,275,204 | 6,534,736 | 6,046,639 | 0 |
Operating Expenses | 4,867,160 | 4,553,297 | 4,811,947 | 4,742,084 | 0 |
Operating Income | 1,841,604 | 2,721,923 | 1,723,770 | 1,305,086 | 0 |
Interest Expense | 462,394 | 291,276 | 126,515 | 142,313 | 0 |
Other Income | -141,178 | -27,899 | -53,092 | 83,842 | 0 |
Pre-tax Income | 1,238,032 | 2,402,748 | 1,544,163 | 1,246,616 | 0 |
Income Tax | 395,669 | 513,360 | 429,248 | 129,074 | 0 |
Net Income Continuous | 842,362 | 1,889,388 | 1,114,915 | 1,117,542 | 0 |
Minority Interests | 22,709 | 32,364 | 16,944 | 28,683 | 0 |
Net Income | $819,653 | $1,857,024 | $1,097,971 | $1,088,858 | $0 |
EPS Basic Total Ops | 0.33 | 0.73 | 0.51 | 0.46 | N/A |
EPS Basic Continuous Ops | 0.33 | 0.73 | 0.43 | 0.43 | N/A |
EPS Diluted Total Ops | 0.31 | 0.73 | 0.51 | 0.46 | N/A |
EPS Diluted Continuous Ops | 0.32 | 0.73 | 0.43 | 0.43 | N/A |
EBITDA(a) | $1,841,605 | $2,721,923 | $1,723,770 | $1,305,086 | $0 |